Nicotine enhances the depressive actions of Aβ1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo

Journal of Neurophysiology

Volumn 89, Issue 6, 2003, Pages 2917-2922

  Freir, D B ^a   Herron, Caroline E ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[12-28]; METHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG; URETHAN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MEMORY; NERVE CELL PLASTICITY; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ACONITINE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ELECTROPHYSIOLOGY; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; LONG-TERM POTENTIATION; MALE; NEURONAL PLASTICITY; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC;

EID: 0038581893     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00996.2002     Document Type: Article

References (41)

1. Abdulla FA, Calaminici MR, Stephenson JD, and Sinden JD. Chronic treatments with cholinoceptor drugs influence spatial learning in rats. Psychopharmacology 111: 508-511, 1993.
2. Alkondon M, Pereira EF, Almeida LE, Randall WR, and Albuquerque EX. Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus. Neuropharmacology 39: 2726-2739, 2000.
3. Alkondon M, Pereira EF, Wonnacott S, and Albuquerque EX. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol Pharmacol 41: 802-808, 1992.
4. Bliss TV and Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39, 1993.
5. Brenner DE, Kukull WA, van Belle G, Bowen JD, McCormick WC, Teri L, and Larson EB. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 43: 293-300, 1993.
6. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, and Hsiao KK. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2: 271-276, 1999.
7. Conroy WG, Liu QS, Nai Q, Margiotta JF, and Berg DK. Potentiation of alpha7-containing nicotinic acetylcholine receptors by select albumins. Mol Pharmacol 63: 419-428, 2003.
8. Cullen WK, Suh YH, Anwyl R, and Rowan MJ. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. Neuroreport 8: 3213-3217, 1997.
9. Dani JA, Radcliffe KA, and Pidoplichko VI. Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas. Eur J Pharmacol 393: 31-38, 2000.
10. Freir DB, Holscher C, and Herron CE. Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J Neurophysiol, 85: 708-713, 2001.
11. Freir DB and Herron CE. Depression of long-term potentiation by β-amyloid peptide [1-40] in area CA1 of the anaesthetized rat: a role for neuronal nicotinic receptors? Ir J Med Sci 170: 19, 2001.
12. Fujii S, Ji Z, Morita N, and Sumikawa K. Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res 846: 137-143, 1999.
13. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, and Dani, JA. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383: 713-716, 1996.
14. 2+ channels. J Neurochem 77: 953-956, 2001.
15. Gurantz D, Margiotta, JF, Harootunian AT, and Dionne VE. Modulation by albumin of neuronal cholinergic sensitivity. Mol Pharmacol 43: 807-812, 1993.
16. Hunter BE, de Fiebre CM, Papke RL, Kem WR, and Meyer EM. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci Lett 168: 130-134, 1994.
17. Itoh A, Akaike T, Sokabe M, Nitta A, Iida R, Olariu A, Yamada K, and Nabeshima T. Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats. Eur J Pharmacol 382: 167-175, 1999.
18. Jones GM, Sahakian BJ, Levy R, Warburton DM, and Gray JA. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108: 485-494, 1992.
19. Jones S and Yakel JL. Functional nicotinic ACh receptors on interneurones in the rat hippocampus. J Physiol 504: 603-610, 1997.
20. Kem WR. The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21). Behav Brain Res 113: 169-181, 2000.
21. Kihara T, Shimohama S, Urushitani M, Sawada H, Kimura J, Kume T, Maeda T, and Akaike A. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res 792: 331-334, 1998.
22. Levin ED. Nicotinic systems and cognitive function. Psychopharmacology 108: 417-431, 1992.
23. Li Y, Papke RL, He YJ, Millard WJ, and Meyer EM. Characterization of the neuroprotective and toxic effects of alpha7 nicotinic receptor activation in PC12 cells. Brain Res 830: 218-225, 1999.
24. Liu Q, Kawai H, and Berg DK. Beta-amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci USA 98: 4734-4739, 2001.
25. 2+ channel activity by beta-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. Modulation by the proinflammatory cytokine interleukin-1β. J Biol Chem 275: 4713-4718, 2000.
26. Matsuyama S, Matsumoto A, Enomoto T, and Nishizaki T. Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus. Eur J Neurosci 12: 3741-3747, 2000.
27. Maurice T, Lockhart BP, and Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 706: 181-193, 1996.
28. McGeer PL, McGeer EG, Suzuki J, Dolman CE, and Nagai T. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology 34: 741-745, 1984.
29. Newhouse PA, Potter A, Corwin J, and Lenox R. Acute nicotinic blockade produces cognitive impairment in normal humans. Psychopharmacology 108: 480-484, 1992.
30. Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, and Murphy DL. Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology 95: 171-175, 1988.
31. Pettit DL, Shao Z, and Yakel JL. Beta-Amyloid (1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci 21: RC120, 2001.
32. Schroder H and Wevers A. Nicotinic acetylcholine receptors in Alzheimers disease. Alzheimers Dis Rev 3: 20-27, 1998.
33. Shalat SL, Seltzer B, Pidcock C, and Baker EL Jr. Risk factors for Alzheimer's disease: a case-control study. Neurology 37: 1630-1633, 1987.
34. Shimohama S and Kihara T. Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity. Biol Psychiatry 49: 233-239, 2001.
35. Turek JW, Kang CH, Campbell JE, Arneric SP, and Sullivan JP. A sensitive technique for the detection of the alpha 7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain. J Neurosci Methods 61: 113-118, 1995.
36. Wang HY, Lee DH, D'Andrea MR, Peterson PA, Shank RP, and Reitz AB. Beta-amyloid (1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 275: 5626-5632, 2000a.
37. Wang HY, Lee DH, Davis CB, and Shank RP. Amyloid peptide Aβ(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem 75: 1155-1161, 2000b.
38. Warburton DM, Rusted JM, and Fowler J. A comparison of the attentional and consolidation hypotheses for the facilitation of memory by nicotine. Psychopharmacology 108: 443-447, 1992.
39. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, and Schmidt AM. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691, 1996.
40. Yan SD, Fu J, Soto C, Chen X, Zhu H, Al-Mohanna F, Collison K, Zhu A, Stern E, Saido T, Tohyama M, Ogawa S, Roher A, and Stern D. An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389: 689-695, 1997.
41. Yankner BA, Duffy LK, and Kirschner DA. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250: 279-282, 1990.